Home » Gene Synthesis & Molecular Biology Services » Off-the-Shelf Plasmids » pGS-scAAV-ITR141-Kan-eGFP

pGS-scAAV-ITR141-Kan-eGFP

A GenScript-innovative self-complementary AAV (scAAV) transfer vector engineered with superior ITR stability and high plasmid yield. This vector includes a truncated AAV2 ITR sequence, a kanamycin resistance gene, GFP for real-time visualization of transgene delivery, a WPRE element for enhanced expression, and an SV40 polyadenylation signal. Ideal for proof-of-concept studies and preclinical validation.
RP-B00039
$1299.00

Ask us a question
Product Introduction
Description A GenScript-innovative self-complementary AAV (scAAV) transfer vector engineered with superior ITR stability and high plasmid yield. This vector includes a truncated AAV2 ITR sequence, a kanamycin resistance gene, GFP for real-time visualization of transgene delivery, a WPRE element for enhanced expression, and an SV40 polyadenylation signal. Ideal for proof-of-concept studies and preclinical validation. More information

Product Specification
Product Type AAV Proprietary Vector, scAAV
Bacteria Resistance Kanamycin
Promoter CMV
C-terminal Tag GFP

Quality Control Specifications
Appearance Clear, colorless, and free from precipitates or foreign particles
Homogeneity (Supercoil) Predominantly Supercoil
Endotoxin Level ≤0.01 EU/μg
Residual RNA Not detectable at 200 ng
E. coli Genomic DNA <15% of all bands via AGE
Restriction Analysis Conforming to reference pattern
Sequencing 100% Sequence Accuracy

Storage
Storage Conditions Store at -20°C
Format 10µg, lyophilized

Disclaimer
Disclaimer For Research Use Only. Not for use in human therapeutics or diagnostic procedures. GenScript Proprietary Vector: Use is subject to terms and conditions ─ view details here: www.genscript.com/genscript-proprietary-vector-terms.html